First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
Clinical trial NCT07169318 · RECRUITING
Trial details
- NCT number
- NCT07169318
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-16
- Primary completion
- 2026-11-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.